StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MORGAN.BO$50.97-1.64%
Fair $50.97+0.0%

MORGAN.BO

Morgan Ventures Limited

Financial Services / Asset ManagementBSE

$50.97

-0.81 (-1.64%)

Fairly Valued+0.0%Fair Value $50.97Fund rank 20/100 · Data gapFallback financials|
SA 42/C
F-Score: 5/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 67.0/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 8/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · MORGAN.BOLocal privado en este navegador · Morgan Ventures Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$505M

P/E

6.2x

↓

EV/EBITDA

4.9x

↓

ROE

28.7%

↑

Gross Margin

95.5%

↑

Debt/Equity

1.92

↑
52-Week Range$51
$35$127

TradingView lightweight chart

MORGAN.BO price, volumen y niveles de valoración

Último $48.63Periodo -59.8%
Fair value: $50.97

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+42.1%

FCF CAGR

—

FCF margin

-17.6%

FCF / Net income

-0.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $200.4M · net income $256.2M · FCF $-35.2M

2022-FY → 2025-FY

Gross margin

95.5%+15.3% pts

Operating margin

219.5%+2.5% pts

Net margin

127.8%+8.3% pts

FCF margin

-17.6%+9.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$200.4M$200.4M$51.7M$81.2M$69.8M
Net Income$256.2M$256.2M$99.5M$65.8M$83.5M
EBITDA$453.8M$453.8M$225.9M$104.4M$151.8M
EPS25.8825.8810.056.648.43
Gross Margin95.5%95.5%96.7%80.2%80.3%
Operating Margin219.5%219.5%437.4%124.5%217.0%
Net Margin127.8%127.8%192.5%81.0%119.5%
Balance Sheet
Debt/Equity1.921.922.452.912.28
Cash Flow
Free Cash Flow$-35.2M$-35.2M$9.7M$-19.5M$-19.0M
Returns
ROE28.7%28.7%15.6%12.2%17.7%
Valuation
P/E6.206.20———
EV/EBITDA4.874.87———
P/B0.560.56———
Growth & Yield
Revenue Growth288.0%288.0%-36.4%16.2%—
EPS Growth157.5%157.5%51.4%-21.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-44.1%

fácil

EPS terminal req.

$4.52

Spread vs growth

201.6%

5Y implied EPS CAGR

-26.7%

fácil

EPS terminal req.

$5.47

Spread vs growth

184.2%

10Y implied EPS CAGR

-10.2%

fácil

EPS terminal req.

$8.81

Spread vs growth

167.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -42.1%

Total return

-42.1%

Start / end P/E

8.4x → 1.9x

EPS bridge

10.05 → 25.88

Residual

-122.1%

EPS growth+157.5%
Multiple rerating-77.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-122.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.